Robert Marsh, DO
Orthopaedic Surgery · Tulsa, OKNPI 1306969738
Payments from drug & device makers
What this record shows
17 manufacturers reported payments, led by Pylant Medical at 53.0% of the total. Reporting peaked in 2022 at $1,449 and has fallen 89.8% since, to $148 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in OK, where the typical reported total is $4,342.
Across 46 payments — averaging $49.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$1K
- Stryker$496
- Smith+Nephew$95
- Johnson & Johnson$78
- Zimmer Biomet$63
- Restor3d, Inc.$57
- plus $287 from 11 others
What the payments were for
- Food & beverage$1,09148%
- Education$1,20052%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 2 | $1,215 |
| Stryker(2 entities) | 20 | $496 |
| Smith+Nephew | 4 | $95 |
| Johnson & Johnson | 3 | $78 |
| Zimmer Biomet | 2 | $63 |
| Restor3d, Inc. | 1 | $57 |
| Vertex | 3 | $51 |
| Organogenesis Inc. | 2 | $43 |
| In2bones USA, LLC | 1 | $42 |
| Polynovo North America LLC | 1 | $37 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Orthalign Inc | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| Mimedx Group, Inc. | 1 | $14 |
| Treace Medical Concepts, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Baxter Healthcare | 1 | $11 |
How this compares
$2,291 in reported general payments places this provider in the 35th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 97 | $1,388 |
| Celecoxib | 52 | $1,152 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 73 | $1,146 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 115 | $862 |
| Pregabalin | 16 | $235 |
| Tramadol Hcl | 22 | $55 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Tulsa
- Yogesh MittalTulsa$6.6M
- Brian ChalkinTulsa$183K
- Kasra AhmadiniaTulsa$138K
- Sarat KunapuliTulsa$136K
- Keivan AbtahiTulsa$77K
- Rodney PlasterTulsa$61K
- Garrett WallerTulsa$52K
- Landon StallingsTulsa$46K
- Travis SmallTulsa$39K
- Blake ShockleyTulsa$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.